Molecular investigation of drug synergy in mycobacteria
For over 50 years, drug combinations have been the gold standard in the therapy of tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb). Clinically, synergistic combinations of drugs are favoured over monotherapy as they allow the use of lower doses and also suppress the development of drug...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Surrey
2017
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.731172 |